OpportunityTitle: Panacea
AdditionalInformationOnEligibility: All responsible sources capable of satisfying the Government&apos;s needs may submit a proposal that shall be considered by DARPA.  See the Eligibility Information section of the BAA for more information.
Description: Human physiology is a limiting factor in the operational readiness of the United States Department of Defense. When the human body is damaged or a physiological system is not functioning optimally, interventions are required to help mend the injury or support continued performance. DARPA seeks to develop new technological approaches in medicinal chemistry and systems pharmacology to expand the druggable proteome and discover new therapeutic tools in the areas of soft tissue pain/inflammation and metabolic stress that limit optimal physiological function.. This new platform technology will directly address needs within the Department of Defense to support the unique physiological demands of the warfighter and provide proof-of-concept for novel drug discovery and development pipelines.
GrantorContactText: BAA Coordinator&lt;br/&gt;Panacea@darpa.mil
CloseDateExplanation: See Full Announcement for details.